WCM
CVS icon

Westend Capital Management’s CVS Health CVS Stock Holding History

Westend Capital Management’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		$295K Sell
3,310
-1,730
-34% -$163K 0.41% 50
2016
Q2 		$483K Sell
5,040
-22,258
-82% -$2.22M 0.7% 41
2016
Q1 		$2.83M Buy
27,298
+2,255
+9% +$219K 3.88% 6
2015
Q4 		$2.45M Buy
25,043
+71
+0.3% +$6.95K 3.36% 10
2015
Q3 		$2.58M Buy
24,972
+2,360
+10% +$248K 3.28% 9
2015
Q2 		$2.39M Buy
22,612
+115
+0.5% +$11.8K 2.78% 8
2015
Q1 		$2.3M Sell
22,497
-1,386
-6% -$140K 2.72% 10
2014
Q4 		$2.3M Sell
23,883
-6,101
-20% -$538K 2.65% 14
2014
Q3 		$2.4M Buy
29,984
+138
+0.5% +$10.9K 2.62% 15
2014
Q2 		$2.3M Sell
29,846
-470
-2% -$35.5K 2.74% 11
2014
Q1 		$2.22M Sell
30,316
-1,309
-4% -$92.5K 2.64% 10
2013
Q4 		$2.26M Buy
+31,625
New +$2.03M 2.43% 14
2013
Q2 		$2.16M Buy
+37,760
New +$2.19M 2.24% 15

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Westend Capital Management's CVS Position: Q3 2016 in Review

Westend Capital Management reduced its CVS Health (CVS) stake by 34% in Q3 2016, selling an estimated $163K and leaving 3,310 shares worth $295K. The position accounts for 0.41% of the portfolio, ranked #50.

Westend Capital Management first reported a position in CVS in Q2 2013 and has held it in 13 quarters since. The position peaked at $2.83M in Q1 2016. 1,563 funds tracked by Wall St. Rank hold CVS as of Q3 2016.

  • Westend Capital Management held 3,310 shares of CVS Health worth $295K as of Q3 2016.
  • Westend Capital Management sold 1,730 CVS Health shares in Q3 2016, an estimated $163K.
  • CVS Health made up 0.41% of Westend Capital Management's portfolio in Q3 2016, its #50 holding.
  • Westend Capital Management first reported a position in CVS Health in Q2 2013 and has held it in 13 quarters since.
  • Westend Capital Management's CVS Health position peaked at $2.83M in Q1 2016.
  • 1,563 funds tracked by Wall St. Rank held CVS Health as of Q3 2016.

Based on Westend Capital Management's 13F filing for Q3 2016, filed 14 Nov 2016.